Adverse events following vaccination against pandemic influenza A (H1N1) 2009 in children

被引:4
|
作者
de Andrade, Gisele Nepomuceno [1 ]
Pimenta, Adriano Marcal [1 ]
Silva, Debora Arreguy [1 ]
Faria Madeira, Anezia Moreira [1 ]
机构
[1] Univ Fed Minas Gerais, Dept Enfermagem Maternoinfantil & Saude Publ, Escola Enfermagem, BR-30130100 Belo Horizonte, MG, Brazil
来源
CADERNOS DE SAUDE PUBLICA | 2012年 / 28卷 / 09期
关键词
Influenza A Virus; H1N1; Subtype; Vaccines; Adverse Effects; Child; A(H1N1) VACCINE; SAFETY; IMMUNOGENICITY; TOLERABILITY; ASTHMA; AGE;
D O I
10.1590/S0102-311X2012000900010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to estimate the frequency of adverse events following vaccination against pandemic influenza A (HIM) 2009 and associated factors in children from six months to two years of age (n = 156). Multivariate Cox regression was used to assess the independent associations between covariates and complaints of at least one adverse event. Strength of association was measured by hazard ratios and respective 95% confidence intervals. Following the first dose, 40.3% of parents reported one or more adverse events in their children, compared to 35.5% after the second dose. Systemic adverse events, specifically irritation, diarrhea, and fever, were more frequent than local reactions at the vaccination site. Incidence rates for adverse events in general and systemic reactions following the first dose were higher in children with concomitant illness or allergies (HR = 3.43, 95%CI: 1.34-8.77 and HR = 2.76, 95%CI: 1.11-6.89). Most events were mild. Cases of high fever, vomiting, and diarrhea prompted parents to seek care for their children at health services.
引用
收藏
页码:1713 / 1724
页数:12
相关论文
共 50 条
  • [1] Pandemic influenza A (H1N1) 2009 vaccination in children: A UK perspective
    de Whalley, Philip C. S.
    Pollard, Andrew J.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2013, 49 (03) : E183 - E188
  • [2] Clinical Assessment of Serious Adverse Events in Children Receiving 2009 H1N1 Vaccination
    Pahud, Barbara A.
    Williams, S. Elizabeth
    Dekker, Cornelia L.
    Halsey, Neal
    LaRussa, Philip
    Baxter, Roger P.
    Klein, Nicola P.
    Marchant, Colin D.
    Sparks, Robert C.
    Jakob, Kathleen
    Aukes, Laurie
    Swope, Susan
    Barnett, Elizabeth
    Lewis, Paige
    Berger, Melvin
    Dreskin, Stephen C.
    Donofrio, Peter D.
    Sejvar, James J.
    Slade, Barbara A.
    Gidudu, Jane
    Vellozzi, Claudia
    Edwards, Kathryn M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : 163 - 168
  • [3] Panvax®: a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009
    McVernon, Jodie
    Nolan, Terry
    EXPERT REVIEW OF VACCINES, 2011, 10 (01) : 35 - 43
  • [4] Neurologic adverse events following influenza A (H1N1) vaccinations in children
    Lee, Seung Jae
    Kim, Young Ok
    Woo, Young Jong
    Kim, Myeong Kyu
    Nam, Tai-Seung
    Cho, Young Kuk
    PEDIATRICS INTERNATIONAL, 2012, 54 (03) : 325 - 330
  • [5] Systemic lupus erythematosus following vaccination against 2009 influenza A (H1N1)
    Morihara, K.
    Arakawa, Y.
    Takenaka, H.
    Morihara, T.
    Katoh, N.
    LUPUS, 2011, 20 (07) : 775 - 776
  • [6] Comparison of Immune Response by Virus Infection and Vaccination to 2009 Pandemic Influenza A/H1N1 in Children
    Kang, Eun Kyeong
    Lim, Jung Sub
    Lee, Jun Ah
    Kim, Dong Ho
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (02) : 274 - 279
  • [7] Active Surveillance of Adverse Events Following Immunization against Pandemic Influenza A (H1N1) in Korea
    Choe, Young June
    Cho, Heeyeon
    Song, Kyung Min
    Kim, Jong-Hee
    Han, Ok Pil
    Kwon, Yoon Hyung
    Bae, Geun Ryang
    Lee, Hoan Jong
    Lee, Jong-Koo
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2011, 64 (04) : 297 - 303
  • [8] Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination
    Williams, S. Elizabeth
    Pahud, Barbara A.
    Vellozzi, Claudia
    Donofrio, Peter D.
    Dekker, Cornelia L.
    Halsey, Neal
    Klein, Nicola P.
    Baxter, Roger P.
    Marchant, Colin D.
    LaRussa, Philip S.
    Barnett, Elizabeth D.
    Tokars, Jerome I.
    McGeeney, Brian E.
    Sparks, Robert C.
    Aukes, Laurie L.
    Jakob, Kathleen
    Coronel, Silvia
    Sejvar, James J.
    Slade, Barbara A.
    Edwards, Kathryn M.
    VACCINE, 2011, 29 (46) : 8302 - 8308
  • [9] Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine
    Busse, William W.
    Peters, Stephen P.
    Fenton, Matthew J.
    Mitchell, Herman
    Bleecker, Eugene R.
    Castro, Mario
    Wenzel, Sally
    Erzurum, Serpil C.
    Fitzpatrick, Anne M.
    Teague, W. Gerald
    Jarjour, Nizar
    Moore, Wendy C.
    Sumino, Kaharu
    Simeone, Scott
    Ratanamaneechat, Suphagaphan
    Penugonda, Madhuri
    Gaston, Benjamin
    Ross, Ted M.
    Sigelman, Steve
    Schiepan, Joella R.
    Zaccaro, Daniel J.
    Crevar, Corey J.
    Carter, Donald M.
    Togias, Alkis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (01) : 130 - U215
  • [10] Influenza A/H1N1 in 2009: a pandemic in evolution
    Clark, Tristan
    Stephenson, Iain
    EXPERT REVIEW OF VACCINES, 2009, 8 (07) : 819 - 822